Skip to main content
. 2020 Dec 2;9(24):e018136. doi: 10.1161/JAHA.120.018136

Figure 1. Median percent change in cholesterol efflux capacity (CEC) in anacetrapib vs placebo.

Figure 1

The percent change was calculated separately in the anacetrapib and placebo groups by taking the difference between the week 24 and week 0 unadjusted values for CEC and lipids and dividing by week 0. The median percent increase was the median difference between the anacetrapib group and the placebo group. 95% CIs for median percent change are shown on each bar in brackets. P<0.0001 for women vs men and diabetes mellitus (DM) vs no DM.